SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1054)2/25/1998 2:05:00 PM
From: scaram(o)uche  Read Replies (1) of 2742
 
from the SC 13D.....

During the month of December, 1997, Warner-Lambert sold an
aggregate of 4,126,365 shares of the Common Stock of the
Issuer on the open market or in private sales in the
following transactions: (i) 164,865 shares on December 8,
1997 on the open market at a price of $0.2029 cents per
share; (ii) 15,000 shares on December 9, 1997 on the open
market at a price of $0.20 cents per share; and (iii)
3,946,500 shares on December 12, 1997 in a private sale to
the Issuer at $0.10 cents per share, which sale closed on
December 31, 1997.
************
So, the deal did close, and I was just simply missing the word "weighted" with respect to the shares outstanding. Sorry. Nonetheless, my opinion still stands...... Galton et al. are going out of their way to make this company appear to be unattractive. Furthermore, I'm still interested in the (apparent) piece of good news, the marked decrease in fully diluted shares out (weighted, 26,903,167 versus 29,045,151). Again, Hal Smith promised to get back to me on this, and I'll also go cruise the 10-Q again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext